Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Interest & Investment Income (2023 - 2024)

Sagimet Biosciences has reported Interest & Investment Income over the past 2 years, most recently at $2.0 million for Q4 2024.

  • Quarterly results put Interest & Investment Income at $2.0 million for Q4 2024, up 51.75% from a year ago — trailing twelve months through Dec 2024 was $8.9 million (up 210.63% YoY), and the annual figure for FY2025 was $5.9 million, down 34.16%.
  • Interest & Investment Income for Q4 2024 was $2.0 million at Sagimet Biosciences, down from $2.3 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for SGMT hit a ceiling of $2.5 million in Q2 2024 and a floor of $180000.0 in Q1 2023.